Post
Gonorrhoea infections in the UK reach an all-time high
During 2020 and 2021, the UK Health Security Agency reported that diagnoses of sexually transmitted infections (STIs) decreased significantly, which …
Annovis Bio completes patient enrolment in study of Parkinson’s drug
Annovis Bio has completed the enrolment of patients in a record nine months from the initiation of its Phase III …
FDA clears EpimAb’s IND for trial of cancer combo therapy
The US Food and Drug Administration (FDA) has granted clearance to EpimAb Biotherapeutics’ investigational new drug (IND) application enabling initiation …
The challenges of clinical data management: Can consent management software help?
Clinical data management (CDM) is one of the most critical aspects of clinical research. Trial data must be accurate to …
LianBio concludes subject enrolment in Phase III TP-03 trial in China
LianBio has completed enrolment in the Phase III LIBRA clinical trial of TP-03 (lotilaner ophthalmic solution, 0.25%) in Demodex blepharitis …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Azafaros begins subject enrolment in Phase II RAINBOW trial of AZ-3102
Azafaros has enrolled the first participant in its Phase II RAINBOW trial of AZ-3102 in GM2 gangliosidosis and Niemann-Pick disease …
Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication
Gritstone bio has reported interim results from an ongoing Phase 1 study evaluating the company’s self-amplifying mRNA (samRNA) vaccine as …
Nexstim pilot study shows boost for depression symptoms
Nexstim has reported results from its pilot study on the use of accelerated intermittent theta burst stimulation (iTBS) protocol in …
Repare reports data from Phase I solid tumours therapy trial
Repare Therapeutics has reported initial proof of concept monotherapy data from the Phase I MYTHIC Module 1 trial of lunresertib …
Ventyx completes enrolment in ulcerative colitis and plaque psoriasis trials
Ventyx Biosciences has completed the enrolment of patients in the Phase II trial of VTX002 in ulcerative colitis and SERENITY …
VistaGen’s nasal spray could reduce menopausal hot flashes, new data suggests
A neuroactive nasal spray could reduce hot flashes during menopause, according to new data from VistaGen Therapeutics. In a 36-patient Phase …
Study shows WHO’s revised hepatitis B vaccination policy is effective
The spread of hepatitis B virus (HBV) presents a challenge to global health and is a major contributor to infant …
ASCO 2023: exciting Phase II efficacy data for BMS’ Breyanzi in CLL/SLL
At the American Society of Clinical Oncology (ASCO) Annual Meeting on 2-6 June 2023, results were presented from the Phase …
Immune-Onc announces dose escalation data from leukaemia therapy trial
Immune-Onc Therapeutics has announced data from the dose escalation part of the Phase I trial of IO-202, a IgG1 monoclonal …
Vera initiates Phase III study of kidney disease therapy
Vera Therapeutics has initiated a Phase III clinical trial of atacicept to treat IgA nephropathy (IgAN), an autoimmune disease of …